Dengue Hemorrhagic fever: The sensitivity and specificity of the world health organization definition for identification of severe cases of dengue in Thailand, 1994-2005

Clinical Infectious Diseases

Volumn 50, Issue 8, 2010, Pages 1135-1143

  Srikiatkhachorn, Anon ^a   Gibbons, Robert V ^d   Green, Sharone ^a   Librety, Daniel H ^a   Thomas, Stephen J ^d   Endy, Timothy P ^b   Vaughn, David W ^c,f   Nisalak, Ananda ^d   Ennis, Francis A ^a   Rothman, Alan L ^a   Nimmannitaya, Suchitra ^e   Kalayanarooj, Siripen ^e  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

^c ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^d Queen Slriklt National Institute of Child Health   (Thailand)

^e GLAXOSMITHKLINE   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLEEDING; BLOOD TRANSFUSION; CASE MANAGEMENT; CHILD; CLINICAL FEATURE; DENGUE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDEMIC DISEASE; FEMALE; FLUID THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PEDIATRIC HOSPITAL; PLEURA EFFUSION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; THAILAND; THROMBOCYTOPENIA; WORLD HEALTH ORGANIZATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DENGUE; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; INFANT; MALE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THAILAND; WORLD HEALTH ORGANIZATION;

EID: 77950240665     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/651268     Document Type: Article

References (29)

1. World Health Organization. Technical guides for diagnosis, treatment, surveillance, prevention and control of dengue haemorrhagic fever. Geneva: World Health Organization (Southeast Asian and Western Pacific Regional Offices), 1975.
2. World Health Organization. Dengue hemorrhagic fever: diagnosis, treatment, prevention and control. 2nd ed. Geneva: World Health Organization, 1997.
3. Nimmannitya S. Clinical spectrum and management of dengue haemorrhagic fever. Southeast Asian J Trop Med Public Health 1987; 18(3): 392-397.
4. Balmaseda A, Hammond SN, Perez MA, et al. Short report: assessment of the World Health Organization scheme for classification of dengue severity in Nicaragua. Am J Trop Med Hyg 2005; 73(6): 1059-1062.
5. Bandyopadhyay S, Lum LC, Kroeger A. Classifying dengue: a review of the difficulties in using the WHO case classification for dengue haemorrhagic fever. Trop Med Int Health 2006; 11(8): 1238-1255.
6. Harris E, Videa E, Perez L, et al. Clinical, epidemiologic, and virologie features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 2000; 63(1-2):5-11.
7. Phuong CX, Nhan NT, Wills B, et al. Evaluation of the World Health Organization standard tourniquet test in the diagnosis of dengue infection in Vietnam. Trop Med Int Health 2002; 7: 125-132.
8. Phuong CX, Nhan NT, Kneen R, et al. Evaluation of an algorithm for integrated management of childhood illness in an area of Vietnam with dengue transmission. Trop Med Int Health 2004; 9: 573-581.
9. Phuong CX, Nhan NT, Kneen R, et al. Clinical diagnosis and assessment of severity of confirmed dengue infections in Vietnamese children: is the world health organization classification system helpful? Am J Trop Med Hyg 2004; 70(2): 172-179.
10. Rigau-Perez JG. Surveillance for an emerging disease: dengue hemorrhagic fever in Puerto Rico, 1988-1997. Puerto Rico Association of Epidemiologists. P R Health Sci J 1999; 18(4): 337-345.
11. Rigau-Perez JG, Laufer MK. Dengue-related deaths in Puerto Rico, 1992-1996: diagnosis and clinical alarm signals. Clin Infect Dis 2006; 42(9): 1241-1246.
12. Setiati TE, Mairuhu AT, Koraka P, et al. Dengue disease severity in Indonesian children: an evaluation of the World Health Organization classification system. BMC Infect Dis 2007; 7: 22.
13. Kalayanarooj S, Vaughn DW, Nimmannitya S, et al. Early clinical and laboratory indicators of acute dengue illness. J Infect Dis 1997; 176(2): 313-321.
14. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992; 30(3): 545-551.
15. Rosen L, Gubler D. The use of mosquitoes to detect and propagate dengue viruses. Am J Trop Med Hyg 1974; 23(6): 1153-1160.
16. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000; 181(1): 2-9.
17. Innis BL, Nisalak A, Nimmannitya S, et al. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am. J Trop Med Hyg 1989; 40(4): 418-427.
18. Cohen SN, Halstead SB. Shock associated with dengue infection. I. Clinical and physiologic manifestations of dengue hemorrhagic fever in Thailand, 1964. J Pediatr 1966; 68(3): 448-456.
19. Holliday MA, Segar WE. The maintenance need for water in parenteral fluid therapy. Pediatrics 1957; 19(5): 823-832.
20. Friedman AL. Pediatric hydration therapy: historical review and a new approach. Kidney Int 2005; 67(1): 380-388.
21. Kularatne SA, Pathirage MM, Medagama UA, Gunasena S, Gunasekara MB. Myocarditis in three patients with dengue virus type DEN 3 infection. Ceylon Med J 2006; 51(2): 75-76.
22. Poovorawan Y, Hutagalung Y, Chongsrisawat V, Boudville I, Bock HL. Dengue virus infection: a major cause of acute hepatic failure in Thai children. Ann Trop Paediatr 2006; 26(1): 17-23.
23. Solomon T, Dung NM, Vaughn DW, et al. Neurological manifestations of dengue infection. Lancet 2000; 355(9209): 1053-1059.
24. Rigau-Perez JG, Bonilla GL. An evaluation of modified case definitions for the detection of dengue hemorrhagic fever. Puerto Rico Association of Epidemiologists. P R Health Sci J 1999; 18(4): 347-352.
25. Srikiatkhachorn A, Krautrachue A, Ratanaprakarn W, et al. Natural history of plasma leakage in dengue hemorrhagic fever: a serial ultrasonographic study. Pediatr Infect Dis J 2007; 26(4): 283-290; discussion 91-92
26. Libraty DH, Endy TP, Houng HS, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002; 185(9): 1213-1221.
27. Cam BV, Fonsmark L, Hue NB, Phuong NT, Poulsen A, Heegaard ED. Prospective case-control study of encephalopathy in children with dengue hemorrhagic fever. Am. J Trop Med Hyg 2001; 65(6): 848-851.
28. de Macedo FC, Nicol AF, Cooper LD, Yearsley M, Pires AR, Nuovo GJ. Histologie, viral, and molecular correlates of dengue fever infection of the liver using highly sensitive immunohistochemistry. Diagn Mol Pathol 2006; 15(4): 223-228.
29. Nimmannitya S, Thisyakorn U, Hemsrichart V. Dengue haemorrhagic fever with unusual manifestations. Southeast Asian J Trop Med Public Health 1987; 18(3): 398-406.